← Leaderboards
Eiman A Mukhtar
Weill Medical Coll Of Cornell Univ
$178,884
Attributed
$178,884
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61.6K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$178,884 · 1
By mechanism
F32$178,884 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- David S. Rickman$6,692,454
- Olivier Elemento$10,592,678
- Benedict Shek Hang Law$4,167,074
- Alexandre Matov$170,886
- Nima Nick Naseri$485,945
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAndrogen Deprivation TherapyAndrogen ReceptorAndrogensBindingCancer EtiologyCancer TherapyCastrationCastration Resistant Prostate CancerCell NucleusCessation Of LifeChemotherapyClinical EfficacyClinically ActionableClinically RelevantCytoplasmData SetDeprivationDiagnosisDisease ResistanceDocetaxelDrug DevelopmentDrug ResistanceAbiraterone
Grant awards (3)
Identification of AR-variant nuclear import pathways in prostate cancer and elucidation of the molecular mechanisms underlying clinical taxane resistance$61,610
F32 · FY2019 · CA · contact PI
Identification of AR-variant nuclear import pathways in prostate cancer and elucidation of the molecular mechanisms underlying clinical taxane resistance$58,654
F32 · FY2018 · CA · contact PI
Identification of AR-variant nuclear import pathways in prostate cancer and elucidation of the molecular mechanisms underlying clinical taxane resistance$58,620
F32 · FY2017 · CA · contact PI